Literature DB >> 9556565

Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart.

S Srivastava1, A Chandra, L F Wang, W E Seifert, B B DaGue, N H Ansari, S K Srivastava, A Bhatnagar.   

Abstract

The metabolism of 4-hydroxy-trans-2-nonenal (HNE), an alpha, beta-unsaturated aldehyde generated during lipid peroxidation, was studied in isolated perfused rat hearts. High performance liquid chromatography separation of radioactive metabolites recovered from [3H]HNE-treated hearts revealed four major peaks. Based on the retention times of synthesized standards, peak I, which accounted for 20% radioactivity administered to the heart, was identified to be due to glutathione conjugates of HNE. Peaks II and III, containing 2 and 37% radioactivity, were assigned to 1, 4-dihydroxy-2-nonene (DHN) and 4-hydroxy-2-nonenoic acid, respectively. Peak IV was due to unmetabolized HNE. The electrospray ionization mass spectrum of peak I revealed two prominent metabolites with m/z values corresponding to [M + H]+ of HNE and DHN conjugates with glutathione. The presence of 4-hydroxy-2-nonenoic acid in peak III was substantiated using gas chromatography-chemical ionization mass spectroscopy. When exposed to sorbinil, an inhibitor of aldose reductase, no GS-DHN was recovered in the coronary effluent, and treatment with cyanamide, an inhibitor of aldehyde dehydrogenase, attenuated 4-hydroxy-2-nonenoic acid formation. These results show that the major metabolic transformations of HNE in rat heart involve conjugation with glutathione and oxidation to 4-hydroxy-2-nonenoic acid. Further metabolism of the GS-HNE conjugate involves aldose reductase-mediated reduction, a reaction catalyzed in vitro by homogenous cardiac aldose reductase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9556565      PMCID: PMC3522116          DOI: 10.1074/jbc.273.18.10893

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Reaction of glutathione with conjugated carbonyls.

Authors:  H Esterbauer; H Zollner; N Scholz
Journal:  Z Naturforsch C Biosci       Date:  1975 Jul-Aug

2.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

3.  Role of cardiac glutathione transferase and of the glutathione S-conjugate export system in biotransformation of 4-hydroxynonenal in the heart.

Authors:  T Ishikawa; H Esterbauer; H Sies
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

4.  Purification and properties of aldehyde reductases from human placenta.

Authors:  B Das; S K Srivastava
Journal:  Biochim Biophys Acta       Date:  1985-07-05

Review 5.  Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment.

Authors:  V J Feron; H P Til; F de Vrijer; R A Woutersen; F R Cassee; P J van Bladeren
Journal:  Mutat Res       Date:  1991 Mar-Apr       Impact factor: 2.433

6.  Doxorubicin-induced acute changes in cytotoxic aldehydes, antioxidant status and cardiac function in the rat.

Authors:  X Luo; Y Evrovsky; D Cole; J Trines; L N Benson; D C Lehotay
Journal:  Biochim Biophys Acta       Date:  1997-02-27

7.  The polyol pathway and glucose 6-phosphate in human endothelial cells cultured in high glucose concentrations.

Authors:  M Lorenzi; S Toledo; G R Boss; M J Lane; D F Montisano
Journal:  Diabetologia       Date:  1987-04       Impact factor: 10.122

8.  Acrolein mercapturates: synthesis, characterization, and assessment of their role in the bladder toxicity of cyclophosphamide.

Authors:  K Ramu; L H Fraiser; B Mamiya; T Ahmed; J P Kehrer
Journal:  Chem Res Toxicol       Date:  1995-06       Impact factor: 3.739

9.  Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids.

Authors:  A Benedetti; M Comporti; H Esterbauer
Journal:  Biochim Biophys Acta       Date:  1980-11-07

10.  Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in Ehrlich mouse ascites cells at different proliferation stages.

Authors:  T Grune; W G Siems; H Zollner; H Esterbauer
Journal:  Cancer Res       Date:  1994-10-01       Impact factor: 12.701

View more
  62 in total

1.  Responses of hypertrophied myocytes to reactive species: implications for glycolysis and electrophile metabolism.

Authors:  Brian E Sansbury; Daniel W Riggs; Robert E Brainard; Joshua K Salabei; Steven P Jones; Bradford G Hill
Journal:  Biochem J       Date:  2011-04-15       Impact factor: 3.857

Review 2.  Cardiovascular redox and ox stress proteomics.

Authors:  Vikas Kumar; Timothy Dean Calamaras; Dagmar Haeussler; Wilson Steven Colucci; Richard Alan Cohen; Mark Errol McComb; David Pimentel; Markus Michael Bachschmid
Journal:  Antioxid Redox Signal       Date:  2012-08-10       Impact factor: 8.401

Review 3.  Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling.

Authors:  Sharad S Singhal; Sharda P Singh; Preeti Singhal; David Horne; Jyotsana Singhal; Sanjay Awasthi
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-23       Impact factor: 4.219

Review 4.  A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases.

Authors:  Saumya Pandey; Satish K Srivastava; Kota V Ramana
Journal:  Expert Opin Investig Drugs       Date:  2012-01-28       Impact factor: 6.206

5.  Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts.

Authors:  Rachel J Keith; Petra Haberzettl; Elena Vladykovskaya; Bradford G Hill; Karin Kaiserova; Sanjay Srivastava; Oleg Barski; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2008-11-11       Impact factor: 5.192

6.  Deficiency of aldose reductase exacerbates early pressure overload-induced cardiac dysfunction and autophagy in mice.

Authors:  Shahid P Baba; Deqing Zhang; Mahavir Singh; Sujith Dassanayaka; Zhengzhi Xie; Ganapathy Jagatheesan; Jingjing Zhao; Virginia K Schmidtke; Kenneth R Brittian; Michael L Merchant; Daniel J Conklin; Steven P Jones; Aruni Bhatnagar
Journal:  J Mol Cell Cardiol       Date:  2018-04-05       Impact factor: 5.000

7.  Myocardial ischaemia inhibits mitochondrial metabolism of 4-hydroxy-trans-2-nonenal.

Authors:  Bradford G Hill; Sunday O Awe; Elena Vladykovskaya; Yonis Ahmed; Si-Qi Liu; Aruni Bhatnagar; Sanjay Srivastava
Journal:  Biochem J       Date:  2009-01-15       Impact factor: 3.857

8.  Mrp1 localization and function in cardiac mitochondria after doxorubicin.

Authors:  Paiboon Jungsuwadee; Ramaneeya Nithipongvanitch; Yumin Chen; Terry D Oberley; D Allan Butterfield; Daret K St Clair; Mary Vore
Journal:  Mol Pharmacol       Date:  2009-02-20       Impact factor: 4.436

9.  Acrolein decreases endothelial cell migration and insulin sensitivity through induction of let-7a.

Authors:  Timothy E O'Toole; Wesley Abplanalp; Xiaohong Li; Nigel Cooper; Daniel J Conklin; Petra Haberzettl; Aruni Bhatnagar
Journal:  Toxicol Sci       Date:  2014-05-08       Impact factor: 4.849

10.  Potential Adverse Public Health Effects Afforded by the Ingestion of Dietary Lipid Oxidation Product Toxins: Significance of Fried Food Sources.

Authors:  Martin Grootveld; Benita C Percival; Justine Leenders; Philippe B Wilson
Journal:  Nutrients       Date:  2020-04-01       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.